Small cell lung cancer(SCLC): Small cell lung cancer, also known as oat cell carcinoma, is an aggressive type of cancer that grows and spreads rapidly. SCLC usually starts in the respiratory tubes (bronchi) of the lungs, in the middle of the chest. SCLC responds well toradiationand chemoth...
Small-cell lung cancer spreads quickly. From 67%-75% of people who develop small cell lung cancerwill have spread the SCLC outside of the lung to other parts of the body at the time of initial diagnosis. Small-cell lung cancer responds well to chemotherapy (using medications to kill cancer...
1.2Small cell lung cancer The main forms of lung cancer includesmall cell lung cancer(SCLC)[3]and non-small cell lung cancer (NSCLC)[2]. Small cell lung cancer is an aggressive disease that accounts for 10–15% of all lung cancers. Metastases to regional lymph nodes or distant site...
Small-cell lung cancer differs from non-small-cell lung cancer in some key ways. Small-cell lung cancer: Grows rapidly. Spreads quickly. Responds well tochemotherapy(usingmedicationsto kill cancer cells) andradiation therapy(using high-dose X-rays or other high-energy rays to kill cancer cells...
Video-assisted thoracoscopic surgery lobectomy or open lobectomy for non-small-cell lung cancer? Minimizing selection bias in observational studies PURPOSE OF REVIEW: Adherence to preventive measures and prescribed medications is the cornerstone of the successful management of hypertension. The role of......
Malignant neoplasm of lungSyndrome综合征A 70-year-old male with a prior history of hypertension and prostate cancer, status post-radical prostatectomy 6 years ago, was found on routine annual examination to have a serum sodium of 130 mEq/dL. His medications included atenolol, aspirin, and ...
Igor I. Rybkin, MD, PhD, discusses the data with these frontline and second-line regimens in extensive-stage small cell lung cancer. Igor I. Rybkin, MD, PhD The addition of an immune checkpoint inhibitor––namely durvalumab (Imfinzi) or atezolizumab (Tecentriq)––to platinum-based ...
cell lymphoma, neuroblastoma, and non-small cell lung cancer are a few examples of cancers in which the anaplastic lymphoma kinase (ALK) gene may be altered. When activated in cancer, the cancer cells may develop and proliferate due to these ALK gene alterations. Gene fusions, chromosomal ...
Rationale: A fatal acute exacerbation (AE) occasionally develops during chemotherapy for small cell lung cancer (SCLC) with comorbid idiopathic pulmonary fibrosis (IPF).Objectives: This study aimed to assess the safety and efficacy of carboplatin, etoposide, and nintedanib combination therapy for unresec...
Purpose: The clinical course of a cohort of patients treated for small-cell lung cancer (SCLC) was evaluated to determine if the obese patients had an increase in therapy-related toxicity. Methods: The study sample included 262 patients with histologically confirmed SCLC treated in clinical trials...